J.P. Marvel Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.62M |
| 2 |
Starbucks
SBUX
|
+$1.74M |
| 3 |
Moderna
MRNA
|
+$866K |
| 4 |
AT&T
T
|
+$447K |
| 5 |
Microsoft
MSFT
|
+$313K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$10.1M |
| 2 |
RTX Corp
RTX
|
+$6.96M |
| 3 |
Nucor
NUE
|
+$3.73M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$3.3M |
| 5 |
Lear
LEA
|
+$2.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.28% |
| 2 | Technology | 23.8% |
| 3 | Financials | 13.23% |
| 4 | Communication Services | 11.26% |
| 5 | Consumer Discretionary | 7.16% |
Similar funds
J.P. Marvel Investment Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, J.P. Marvel Investment Advisors held 71 positions worth $264M, down 24% from $346M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
J.P. Marvel Investment Advisors withdrew a net $24.6M in Q1 2020, closing 7 positions and reducing 25 holdings. Its most notable exit was Walt Disney, an estimated $10.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, J.P. Marvel Investment Advisors opened a new position in Starbucks worth $1.41M.
- J.P. Marvel Investment Advisors's largest Q1 2020 buy was Starbucks: 21,480 shares worth $1.41M.
- J.P. Marvel Investment Advisors added most to CVS Health in Q1 2020, an estimated $2.62M increase.
- J.P. Marvel Investment Advisors's biggest Q1 2020 reduction was Lear, cutting an estimated $2.71M.
- J.P. Marvel Investment Advisors fully exited Walt Disney in Q1 2020, selling an estimated $10.1M.
- J.P. Marvel Investment Advisors's ten largest holdings make up 41% of its $264M portfolio in Q1 2020.
- J.P. Marvel Investment Advisors opened 1 new position and closed 7 in Q1 2020.
- J.P. Marvel Investment Advisors's portfolio value fell 24% quarter-over-quarter to $264M.
Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2020, filed 9 Sep 2021.